MedTrace Logo

Safety of Intravenous Lidocaine Infusions

NCT01091935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2010-03-24

No results posted yet for this study

Summary

The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.

Conditions

  • Neuropathic Pain

Sponsors & Collaborators

  • University of Western Ontario, Canada

    collaborator OTHER

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Patricia K Morley-Forster, MD, FRCPC · Associate Professor,Dept of Anesthesia and Perioperative Medicine,University of Western Ontario, Lawson Health Research Institute

  • Patricia K Morley-Forster, MD, FRCPC · Associate Professor, University of Western Ontario, Lawson Health Research Institute

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091935 on ClinicalTrials.gov